Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults
Clinical trial NCT06777173 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06777173
- Sponsor
- Beijing Ditan Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2026-11-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.